Interacting Drugs |
Guaifenesin, dextromethorphan, and phenylephrine vs Cannabinoids |
Security Level |
|
Mechanism |
Cannabinoids: May enhance the tachycardic effect of Sympathomimetics. |
Management |
Monitor therapy |
Guaifenesin, dextromethorphan, and phenylephrine vs Cannabinoids
Post Review about Guaifenesin, dextromethorphan, and phenylephrine vs Cannabinoids Click here to cancel reply.
Other Interactions of Guaifenesin, dextromethorphan, and phenylephrine
Other Interactions of Cannabinoids
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.